EE678 Time and Cost Savings from Adopting an Alternative Dosing Schedule with Pembrolizumab for Patients with Advanced Melanoma in Greece
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.943
https://www.valueinhealthjournal.com/article/S1098-3015(23)04073-1/fulltext
Title :
EE678 Time and Cost Savings from Adopting an Alternative Dosing Schedule with Pembrolizumab for Patients with Advanced Melanoma in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04073-1&doi=10.1016/j.jval.2023.09.943
First page :
Section Title :
Open access? :
No
Section Order :
10437